title: Treatment decisions for MRSA in patients with cystic fibrosis (CF): when is enough, enough?
authors.affiliation: QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.|Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia.
authors.forename: Scott C
authors.identifier: 0000-0001-8651-7139
authors.initials: SC
authors.lastname: Bell
authors.affiliation: Departments of Medicine and Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA.
authors.forename: Patrick A
authors.initials: PA
authors.lastname: Flume
mesh_terms: D000900:Anti-Bacterial Agents; D003550:Cystic Fibrosis; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus; D013211:Staphylococcus aureus
chemical_list: D000900:Anti-Bacterial Agents
keywords: Cystic Fibrosis; Respiratory Infection